Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR1915 host gene (MIR1915HG) encodes a long non-coding RNA (lncRNA) that functions as the host gene for microRNA-1915 (miR-1915)[3][4]. It is also known by the gene symbols C10orf114 and CASC10. The lncRNA itself does not encode a functional protein but instead acts through its RNA products, particularly via hosting the miR-1915 microRNA. MIR1915HG is located on human chromosome 10 and is classified among non-coding RNA genes[3][4]. The mature microRNA derived from this host gene, miR-1915-3p, has been shown to be dysregulated in several cancers—including colorectal cancer, breast cancer, lung cancer, and thyroid cancer—where it is variably described as having tumor suppressor or oncogenic roles depending on cancer context[1]. Current research recommends miR-1915-3p and, by implication, its host gene, as a candidate biomarker for cancer diagnosis and a potential subject for future therapeutic targeting[1]. However, there are no known direct drug interactions or established clinical safety concerns related to MIR1915HG itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR1915 host gene (MIR1915HG).